SII head Adar Poonawalla, 39, is planning to begin production of a SARS-CoV-2 vaccine now. By autumn, he hopes to have produced 40 million doses, at which time it will become clear if it is granted approval – or not.
If it is approved, Poonawalla intends to make at least half of the doses available to India, with the rest going to countries that don’t have their own vaccine. If approval is not forthcoming, it will all be discarded.
Poonawalla’s company joined the project at its own risk. In the worst-case scenario, he might lose a few million euros of his multi-billion-euro nest egg. But should everything go well, he’ll be a hero by the end of the year – and have the reputation for being a visionary businessman.